Clinical trial
Does the Rapid Intravenous Administration of Oxytocin After Delivery of the Baby…
NCT00257803 · University of British Columbia, Other · Completed
Key facts
| NCT number | NCT00257803 |
|---|---|
| Title | Does the Rapid Intravenous Administration of Oxytocin After Delivery of the Baby Decrease the Bleeding During Cesarean Section in Women at Risk of Bleeding During Cesarean Section? |
| Official title | A Randomized Double-blind Comparison of a 5 Unit Intravenous Oxytocin Bolus Versus Placebo as a Strategy to Prevent Uterine Atony at Cesarean Section in Women Who Are at Increased Risk of Post-Partum Hemorrhage |
| Lead sponsor | University of British Columbia, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Postpartum Hemorrhage |
| Intervention type | Drug |
| Interventions | Oxytocin, Saline solution |
| Enrollment | 150 |
| Start date | Nov 1, 2005 |
| Primary completion | Oct 1, 2006 |
| Completion | Dec 1, 2012 |
| First posted | Nov 23, 2005 |
| Last update posted | Mar 17, 2014 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: